お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
980924

がん生検の世界市場:業界分析、規模、シェア、成長、動向および予測(2019年~2026年)

Global Cancer Biopsy Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

出版日: | 発行: Value Market Research | ページ情報: 英文 169 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=108.90円
がん生検の世界市場:業界分析、規模、シェア、成長、動向および予測(2019年~2026年)
出版日: 2021年01月01日
発行: Value Market Research
ページ情報: 英文 169 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界のがん生検市場について調査しており、市場の機会や動向、成長および抑制要因、COVID-19パンデミックの影響、製品・タイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 業界分析

  • 市場力学
  • 市場の成長要因
  • 市場の抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
  • 潜在的なバイヤーのリスト
  • マーケティングチャネル

第5章 COVID-19の発生の影響分析

  • Covid-19発生の影響分析
  • 生産量:輸入・輸出・需要別の影響分析
  • 市場:COVID-19前/後
  • COVID-19パンデミックの推定される影響
  • COVID-19:ミクロおよびマクロ因子分析

第6章 市場分析:製品別

  • 概要
  • 過去/予測データ
  • 製品別分析
  • 機器
  • キットおよび消耗品
  • サービス

第7章 市場分析:タイプ別

  • 概要
  • 過去/予測データ
  • タイプ別分析
  • 組織生検(針生検、穿刺吸引生検(FNA)、コア針生検(CNB)、外科生検)
  • リキッドバイオプシー
  • その他

第8章 市場分析:用途別

  • 概要
  • 過去/予測データ
  • 用途別分析
  • 乳がん市場
  • 結腸直腸がん
  • 子宮頸がん
  • 肺がん
  • 前立腺がん
  • 皮膚がん
  • 血液がん
  • 腎臓がん
  • 肝臓がん
  • 膵臓がん
  • 卵巣がん

第9章 市場分析:地域別

  • 地域の見通し
  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東とアフリカ

第10章 競合情勢

  • 市場競争
  • 提携/協業/契約
  • 合併と買収
  • 新製品の発売
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中率
  • Qiagen NV
  • GRAIL, Inc
  • Illumina, Inc.
  • ANGLE Plc
  • BD (Becton, Dickinson And Company)
  • Myriad Genetics
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Lucence Diagnostics Pte. Ltd.
  • Guardant Health
  • Exact Sciences Corporation
  • Biodesix (Integrated Diagnostics)
  • Freenome Holdings, Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product (USD MN)
  • Instruments Market by Geography (USD MN)
  • Kits and Consumables Market by Geography (USD MN)
  • Services Market by Geography (USD MN)
  • Analysis Market by Type (USD MN)
  • Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
  • Liquid Biopsies Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Colorectal Cancer Market by Geography (USD MN)
  • Cervical Cancers Market by Geography (USD MN)
  • Lung Cancers Market by Geography (USD MN)
  • Prostate Cancers Market by Geography (USD MN)
  • Skin Cancers Market by Geography (USD MN)
  • Blood Cancers Market by Geography (USD MN)
  • Kidney Cancers Market by Geography (USD MN)
  • Liver Cancers Market by Geography (USD MN)
  • Pancreatic Cancers Market by Geography (USD MN)
  • Ovarian Cancers Market by Geography (USD MN)
  • Global Cancer Biopsy Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Cancer Biopsy Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Biopsy Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Instruments Market by Geography (USD MN)
  • Kits and Consumables Market by Geography (USD MN)
  • Services Market by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Geography (USD MN)
  • Liquid Biopsies Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Breast Cancer Market by Geography (USD MN)
  • Colorectal Cancer Market by Geography (USD MN)
  • Cervical Cancers Market by Geography (USD MN)
  • Lung Cancers Market by Geography (USD MN)
  • Prostate Cancers Market by Geography (USD MN)
  • Skin Cancers Market by Geography (USD MN)
  • Blood Cancers Market by Geography (USD MN)
  • Kidney Cancers Market by Geography (USD MN)
  • Liver Cancers Market by Geography (USD MN)
  • Pancreatic Cancers Market by Geography (USD MN)
  • Ovarian Cancers Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2019

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次

Value Market Research's latest report on the Global Cancer Biopsy Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the forecast period of 2020-2026.

The global cancer biopsy market report provides a complete evaluation of the market for the forecast period. The report consists of various segments as well as an analysis of the factors playing a significant role in the market. The factors include the drivers, restraints, challenges and opportunities and the impact of these factors on the market has been provided in the report. The drivers and restraints are classified as intrinsic factors while the opportunities and challenges are classified as extrinsic factors of the market. The global cancer biopsy market study provides an insight on the developments of the market in terms of revenue throughout the specified period.

This report provides a complete analysis for the global cancer biopsy market. An in-depth secondary research, primary interviews and in-house expert reviews are responsible for providing the market estimates for the global cancer biopsy market. These market estimates have been put together by studying the impact of different social, political and economic factors along with the current market dynamics that are affecting the global cancer biopsy market growth.

The report begins with the market overview, followed by a crisp executive summary. The Porter's Five Forces analysis covered in this study will assist in understanding the five forces namely buyers bargaining power, suppliers bargaining power, threat of new entrants, the threat of substitutes and the degree of competition in the global cancer biopsy market. It also helps to explain the various participants such as system integrators, intermediaries and end users within the market. The report by Value Market Research also focuses on the competitive landscape of the global cancer biopsy market.

The market analysis involves a section exclusively to list the major players of the global cancer biopsy market wherein our analysts provide an insight into the financial statements of all the key players along with its key development product. The company profile section in the report also provides a business overview and financial information. The companies provided in this section can be customized as per the client's requirement.

The Cancer Biopsy Market Report Segments the market as below:

By Product

  • Instruments
  • Kits and Consumables
  • Services

By Type

  • Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies)
  • Liquid Biopsies
  • Others

By Application

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Liver Cancers
  • Pancreatic Cancers
  • Ovarian Cancers
  • Others

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CANCER BIOPSY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product
    • 3.7.2 By Type
    • 3.7.3 By Application
    • 3.7.4 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Instruments Market by Regions
  • 6.6 Kits and Consumables Market by Regions
  • 6.5 Services Market by Regions

7 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 Tissue Biopsies( Needle Biopsies, Fine Needle Aspiration (FNA), Core Needle Biopsy (CNB), Surgical Biopsies) Market by Regions
  • 7.5 Liquid Biopsies Market by Regions
  • 7.6 Others Market by Regions

8 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Breast Cancer Market by Regions
  • 8.5 Colorectal Cancer Market by Regions
  • 8.6 Cervical Cancers Market by Regions
  • 8.7 Lung Cancers Market by Regions
  • 8.8 Prostate Cancers Market by Regions
  • 8.9 Skin Cancers Market by Regions
  • 8.10. Blood Cancers Market by Regions
  • 8.11 Kidney Cancers Market by Regions
  • 8.12 Liver Cancers Market by Regions
  • 8.13 Pancreatic Cancers Market by Regions
  • 8.14 Ovarian Cancers Market by Regions

9 . GLOBAL CANCER BIOPSY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America
    • 9.3.1. Overview, Historic and Forecast Data
    • 9.3.2. North America By Segment
    • 9.3.3. North America By Country
    • 9.3.4. United State
    • 9.3.5. Canada
    • 9.3.6. Mexico
  • 9.4. Europe
    • 9.4.1. Overview, Historic and Forecast Data
    • 9.4.2. Europe by Segment
    • 9.4.3. Europe by Country
    • 9.4.4. United Kingdom
    • 9.4.5. France
    • 9.4.6. Germany
    • 9.4.7. Italy
    • 9.4.8. Russia
    • 9.4.9. Rest Of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Overview, Historic and Forecast Data
    • 9.5.2. Asia Pacific by Segment
    • 9.5.3. Asia Pacific by Country
    • 9.5.4. China
    • 9.5.5. India
    • 9.5.6. Japan
    • 9.5.7. South Korea
    • 9.5.8. Australia
    • 9.5.9. Rest Of Asia Pacific
  • 9.6. Latin America
    • 9.6.1. Overview, Historic and Forecast Data
    • 9.6.2. Latin America by Segment
    • 9.6.3. Latin America by Country
    • 9.6.4. Brazil
    • 9.6.5. Argentina
    • 9.6.6. Peru
    • 9.6.7. Chile
    • 9.6.8. Rest of Latin America
  • 9.7. Middle East & Africa
    • 9.7.1. Overview, Historic and Forecast Data
    • 9.7.2. Middle East & Africa by Segment
    • 9.7.3. Middle East & Africa by Country
    • 9.7.4. Saudi Arabia
    • 9.7.5. UAE
    • 9.7.6. Israel
    • 9.7.7. South Africa
    • 9.7.8. Rest Of Middle East And Africa

10 . COMPETITIVE LANDSCAPE OF THE CANCER BIOPSY COMPANIES

  • 10.1. Cancer Biopsy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF CANCER BIOPSY INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Qiagen N.V.
    • 11.3.1. Company Overview
    • 11.3.2. Financials
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. GRAIL, Inc
    • 11.4.1. Company Overview
    • 11.4.2. Financials
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Illumina, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financials
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. ANGLE Plc
    • 11.6.1. Company Overview
    • 11.6.2. Financials
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. BD (Becton, Dickinson And Company)
    • 11.7.1. Company Overview
    • 11.7.2. Financials
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Myriad Genetics
    • 11.8.1. Company Overview
    • 11.8.2. Financials
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Hologic, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financials
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Biocept, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financials
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Thermo Fisher Scientific, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financials
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Danaher
    • 11.12.1. Company Overview
    • 11.12.2. Financials
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. F. Hoffmann-La Roche Ltd.
    • 11.13.1. Company Overview
    • 11.13.2. Financials
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Lucence Diagnostics Pte. Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financials
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Guardant Health
    • 11.15.1. Company Overview
    • 11.15.2. Financials
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Exact Sciences Corporation
    • 11.16.1. Company Overview
    • 11.16.2. Financials
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. Biodesix (Integrated Diagnostics)
    • 11.17.1. Company Overview
    • 11.17.2. Financials
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. Freenome Holdings, Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Financials
    • 11.18.3. Products
    • 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.